http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111991376-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fbb91e3f8cdf858527814216aa11142
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
filingDate 2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1257276f5cc36834af63dad6ea3c6fcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1ec063712a8de48a4e0259eb5dc5b82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04a7eeaf982f118742553a3c20f10b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde6774b89c034364ff77df2acdacd6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e4306f818b92aca371af6523b7f9d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623d86e0d833d3eaf19e0685ed12f92c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754ad3b159acc7bdfe2d7fe8a650cc84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ce2fc792d15229af219fe0cc3a8d31d
publicationDate 2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111991376-A
titleOfInvention Application of turmeric in preparation of products for preventing and treating ulcerative colitis and regulating intestinal flora
abstract The invention belongs to the technical field of medicine and discloses the application of turmeric in the preparation of products for preventing and treating ulcerative colitis. The present invention proves for the first time that turmeric can regulate intestinal flora, inhibit the pathological degree of ulcerative colitis, control the reaction of ulcerative colitis, thereby inhibiting the activation of NF-κB p65 cells and down-regulating the expression of inflammatory factors, and alleviating the effects of subsequent DSS. It can be used to regulate the intestinal flora of the human body to treat or prevent ulcerative colitis; in addition, a new use of turmeric is provided. , that is, its application in the prevention and treatment of ulcerative colitis, and also provides a new option for the treatment of ulcerative colitis.
priorityDate 2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012023146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010316631-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014099390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008051474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011125070-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416009810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14367555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID558221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426210653

Total number of triples: 34.